Recurrent ulcerative tubular apocrine adenoma of the eyelid mimicking eyelid malignancy: A case report and literature review.

Ashwaq Y Asiri, Hamad Alsulaiman, Hind M Alkatan, Rawan N Althaqib

Abstract readCase Reports

In one paragraph

Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ashwaq Y AsiriDepartment of Ophthalmology, College of Medicine, King Khalid University, Abha, Saudi Arabia; King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. Electronic address: asyaasiri@kku.edu.sa.

Hamad AlsulaimanKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. Electronic address: hsulaiman@kkesh.med.sa.

Hind M AlkatanDepartments of Ophthalmology and Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia. Electronic address: hkatan@ksu.edu.sa.

Rawan N AlthaqibKing Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. Electronic address: rthaqib@kkesh.med.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe eyelid is a common site for cutaneous tumors; however, tubular apocrine adenoma is a rare presentation. The clinical presentation is variable and surgical excision is effective with low risk for recurrence. PRESENTATION OF CASE: We report a 40-year-old female with recurrent tubular apocrine adenoma of eyelid mimicking eyelid malignancy. Diagnostic incisional biopsy demonstrated dermal benign tubular-like proliferations lined by bilayer of apocrine epithelium within a background of hyalinized stroma. DISCUSSION: Isolated tubular apocrine adenoma of the eyelid is rare with individual cases being found in the literature. Previously reported recurring apocrine eyelid tumors were involving older patients than our case and the recurrence occurred within 2-3 years.

conclusionOur case is unique as the patient was younger and the recurrence occurred after a longer period. Our report provides insight into the clinical features, histopathologic characteristics and treatment of tubular apocrine adenoma of the eyelid.

Indexed as

ApocrineCase reportEyelidRecurrentTubular adenoma

Identifiers

PMID39884172

DOI10.1016/j.ijscr.2025.110929

PMCPMC11831889

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.